Revenge of the Nerds
Biotech companies, for years at the mercy of their deep-pocketed pharma partners, are finally holding the strings.
We 'Heart' Biomarkers, Say AstraZeneca and Merck
Cardio competitors team up to find new ways of preventing heart attacks.
Lilly Closes Zyprexa Case
(And the Times' front-page pounding had nothing to do with it.)
